Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, December 8, 2025

Phase-specific multimodal biomarkers enable explainable assessment of upper limb dysfunction in chronic stroke

'Assessments' don't get you recovered, only EXACT PROTOCOLS DO! SURVIVORS WANT RECOVERTY! GET THERE!

I'd fire everyone involved with this crapola! You're 'assessing' based on the failure of the status quo! Change the status quo, you blithering idiots!

 Phase-specific multimodal biomarkers enable explainable assessment of upper limb dysfunction in chronic stroke


Lei Li,Lei Li1,2Junhong WangJunhong Wang3Jingcheng ChenJingcheng Chen4Shaoming Sun,
Shaoming Sun1,3*Wei Peng,
Wei Peng1,4*
  • 1Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China
  • 2University of Science and Technology of China, Hefei, China
  • 3Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China
  • 4CAS Hefei Institute of Technology Innovation, Hefei, China

Background: Objective and precise assessment of upper limb dysfunction post-stroke is critical for guiding rehabilitation. While promising, current methods using wearable sensors and machine learning (ML) often lack interpretability and neglect underlying, phase-specific kinetic deficits (e.g., muscle forces and joint torques) within functional tasks. This study aimed to develop and validate an explainable assessment framework that leverages musculoskeletal kinetic modeling to extract phase-specific, multimodal (kinematic and kinetic) biomarkers to assess upper limb dysfunction in chronic stroke.

Methods: Sixty-five adults with chronic stroke and 20 healthy controls performed a standardized hand-to-mouth (HTM) task. Stroke participants were allocated to a model-development cohort (n = 47) and an independent test cohort (n = 18). Using IMU and sEMG data, we employed musculoskeletal modeling to extract phase-specific kinematic (e.g., inter-joint coordination, trunk displacement) and kinetic (e.g., mechanical work, smoothness, co-contraction index) biomarkers from four task phases. A Lasso regression model was trained to predict FMA-UL scores, validated via 5-fold cross-validation and the independent test cohort. Explainable AI (SHAP) was used to identify key predictive features.

Results: Compared with controls, patients showed phase-specific alterations including greater trunk displacement and reduced inter-joint coordination and mechanical work (all p < 0.05). The Lasso model achieved strong performance in internal validation (R2 = 0.932; MAE = 0.799) and generalized well to the independent test cohort (R2 = 0.881; MAE = 0.954). SHAP identified trunk displacement in phase 2 (TD_2), elbow–shoulder coordination in phase 3 (IC_elb_elv_3), and trunk displacement in phase 3 (TD_3) as dominant predictors; larger trunk displacement contributed negatively to predicted FMA-UL scores.

Conclusion: Integrating phase-specific multimodal biomarkers with explainable ML yields an interpretable upper-limb dysfunction. By highlighting phase-specific kinetic and kinematic targets (e.g., trunk compensation and inter-joint coordination), the framework supports individualized, precision rehabilitation.

No comments:

Post a Comment